Gubra AS (CHIX:GUBRAC) EBITDA Margin % : -17.19% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Gubra AS EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Gubra AS's EBITDA for the six months ended in Dec. 2023 was kr-17.7 Mil. Gubra AS's Revenue for the six months ended in Dec. 2023 was kr103.2 Mil. Therefore, Gubra AS's EBITDA margin for the quarter that ended in Dec. 2023 was -17.19%.

Gubra AS EBITDA Margin % Historical Data

The historical data trend for Gubra AS's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS EBITDA Margin % Chart

Gubra AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

14.18

38.74

7.35

-13.69

Gubra AS Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial			-	-9.22	16.51	-19.91	-17.19

Competitive Comparison of Gubra AS's EBITDA Margin %

For the Biotechnology subindustry, Gubra AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gubra AS's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Gubra AS's EBITDA Margin % falls into.

Gubra AS EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Gubra AS's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-28.064	/	205.005
	=	-13.69 %

Gubra AS's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-17.743	/	103.188
	=	-17.19 %

Gubra AS (CHIX:GUBRAc) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Gubra AS EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Gubra AS's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gubra AS (CHIX:GUBRAC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

GUBRA:Denmark PI3:Germany

Address

Hørsholm Kongevej 11B, Hørsholm, DNK, 2970

Website

https://www.gubra.dk

Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (CHIX:GUBRAC) Headlines

No Headlines